Clinical Trials Arena February 19, 2025
Clinical trial complexity has significantly increased in the past decade, creating strengthening headwinds in trial duration and cost for developers. But what are the factors behind this phenomenon, and how can the industry adapt and innovate to remain productive?
The pharmaceutical industry is facing growing complexity in clinical trials, contributing to longer timelines and ultimately higher costs. These complexities are hindering the industry’s ability to bring new therapies to market quickly and effectively, thus reducing sponsors’ ROI.
Clinical trials saw a 67% increase in the number of procedures in Phase II and III protocols between 2009-2020[i] , and sites are now using more than 20 technology systems daily[ii] – just two indicative metrics that characterize the complexity of today’s landscape....
Today's Sponsors
Today's Sponsor